0001801885-20-000001.txt : 20200225 0001801885-20-000001.hdr.sgml : 20200225 20200225153413 ACCESSION NUMBER: 0001801885-20-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20200225 DATE AS OF CHANGE: 20200225 EFFECTIVENESS DATE: 20200225 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Oisin Biotechnologies, Inc. CENTRAL INDEX KEY: 0001801885 IRS NUMBER: 465167496 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-361313 FILM NUMBER: 20650355 BUSINESS ADDRESS: STREET 1: 800 5TH AVENUE, SUITE 4100 CITY: SEATTLE STATE: WA ZIP: 98104 BUSINESS PHONE: 206-880-1166 MAIL ADDRESS: STREET 1: 800 5TH AVENUE, SUITE 4100 CITY: SEATTLE STATE: WA ZIP: 98104 D 1 primary_doc.xml X0708 D LIVE 0001801885 Oisin Biotechnologies, Inc. 800 5TH AVENUE, SUITE 4100 SEATTLE WA WASHINGTON 98104 206-880-1166 DELAWARE None None Corporation true Matthew Scholz 800 5th Avenue, Suite 4100 Seattle WA WASHINGTON 98104 Executive Officer Director Gary Hudson 800 5th Avenue, Suite 4100 Seattle WA WASHINGTON 98104 Director David Gobel 800 5th Avenue, Suite 4100 Seattle WA WASHINGTON 98104 Director Other Decline to Disclose 06b false 2017-12-19 true true false 0 3000000 2974976 25024 false 48 0 0 0 false Oisin Biotechnologies, Inc. /s/Matthew Scholz Matthew Scholz President 2020-02-25